2/2/2023 2:21:44 PM - Faces resistance due to overhead supply up to the $35 level. Reported earnings +18% on +27% sales revenues for the Sep &#39;22 quarter, breaking a streak of 3 consecutive quarterly comparisons showing earnings increases above the +25% minimum guideline (C criteria). Annual earnings (A criteria) had a downturn in FY &#39;20.<br><hr>4/5/2022 12:26:24 PM - Faces resistance due to overhead supply up to the $35 level. Reported earnings +67% on +66% sales revenues for the Dec &#39;21 quarter, its 3rd consecutive quarterly comparison showing earnings increases above the +25% minimum guideline (C criteria). Annual earnings (A criteria) had a downturn in FY &#39;20.<br><hr>5/14/2019 2:10:46 PM - Found support near its 50 DMA line ($23.36) on the prior session. Reported earnings +54% on +10% sales revenues for the Mar &#39;19 quarter. Prior quarterly comparisons showed earnings increases above the +25% minimum guideline (C criteria), however, sequential comparisons showed deceleration in its sales revenues growth rate.<br><hr>